NCT02564107 2016-11-02
A Study of Ibandronate (Bondronat) in Participants With Metastatic Bone Disease
Hoffmann-La Roche
Phase 4 Completed
Clinical Trials
3 trialsNCT00492843 2016-02-17
Loading Dose or Standard Dose of Intravenous Ibandronate in Treating Patients With Lung Cancer and Skeletal Metastasis
Chinese Society of Lung Cancer
Phase 4 Terminated
NCT02553707 2015-09-17
A Study to Assess the Short Term Efficacy of Intravenous Ibandronate (Bondronat) in Participants With Metastatic Bone Pain Due to Breast Cancer
Hoffmann-La Roche
Phase 4 Completed